Immunome Analyst Price Targets

Immunome Inc

IMNMNASDAQ

$24.67

-0.30-1.2%

al cierre: Sep 11, 5:00 PM EST

$24.67

N/A

After hour: Sep 11, 4:00 PM EST

Wall Street analyst price targets and consensus rating for Immunome (IMNM).

Price Target Range — 12 Quarters

Analyst Consensus — 14 Analysts

14Buy

Consensus RatingBuy# Analysts14Avg. Consensus PT$32Upside to Avg. PT+29.7%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 10, 2026	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$40
Aug 12, 2026	Truist Securities	Supawat Thongthip	PT Raise	Buy	$37→$38
Aug 12, 2026	Wedbush	David Nierengarten	PT Raise	Outperform	$31→$35
Jul 21, 2026	Wedbush	David Nierengarten	Maintained	Outperform	$31
Jun 12, 2026	Wedbush	David Nierengarten	Maintained	Outperform	$31
May 28, 2026	Truist Securities	Supawat Thongthip	PT Raise	Buy	$36→$37
May 28, 2026	Barclays	Lukas Shumway	Initiate	Overweight	$36
May 15, 2026	Leerink Partners	Andrew Berens	PT Cut	Outperform	$37→$33
May 13, 2026	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$40
Mar 4, 2026	Craig-Hallum	Adam Vogel	PT Raise	Buy	$33→$36
Mar 4, 2026	Stephens & Co.	Sudan Loganathan	PT Cut	Overweight	$33→$30
Feb 12, 2026	HC Wainwright & Co.	Andres Y. Maldonado	Initiate	Buy	$40
Jan 15, 2026	Wedbush	David Nierengarten	Maintained	Outperform	$31
Dec 16, 2025	Lake Street	Chad Messer	PT Raise	Buy	$22→$32
Dec 16, 2025	Evercore ISI Group	Cory Kasimov	PT Raise	Outperform	$18→$40
Dec 16, 2025	Guggenheim	Michael Schmidt	PT Raise	Buy	$25→$35
Dec 1, 2025	Truist Securities	Karina Rabayeva	Initiate	Buy	$36
Nov 17, 2025	Stephens & Co.	Sudan Loganathan	PT Raise	Overweight	$25→$33
Sep 22, 2025	Goldman Sachs	Salveen Richter	Initiate	Buy	$26
Sep 5, 2025	Craig-Hallum	Adam Vogel	Initiate	Buy	$26